| Filed On | Filing |
|---|---|
| 12 Nov 2024 | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP |
| 02 Jul 2024 | SC 13D/A |
| 11 Jan 2024 | SC 13D/A |
| 11 Jan 2023 |
Form 4: Wynnefield Partners Small Cap Value Lp I, 10% owner and 7 others
Acquired 3,250 Series A Convertible Preferred Stock (Open Market Purchase) ($3.25M) |
| 29 Nov 2022 |
Form 4: Wynnefield Partners Small Cap Value Lp I, 10% owner and 7 others
Bought 627,746 shares ($5M) |
| 13 Feb 2009 | AMENDMENT TO SCHEDULE 13G |
| 10 Apr 2008 | LIFECORE BIOMEDICAL INC 13GA2 |
| 07 Apr 2008 | CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION |
| 28 Mar 2008 | EFFECT |
| 28 Mar 2008 | EFFECT |
| 28 Mar 2008 | EFFECT |
| 28 Mar 2008 | EFFECT |
| 28 Mar 2008 | EFFECT |
| 28 Mar 2008 |
Form 4: Runnells John E, Director
Disposed of 65,000 Non-Qualified Stock Option (Disposition to Issuer) ($393K) |
| 27 Mar 2008 |
Form 4: Emerson Martin J, Director
Disposed of 18,750 Stock Option (Right to Buy) (Disposition to Issuer) ($44.3K) |
| 27 Mar 2008 |
Form 4: Thacker Kipling, VP of New Business Development
Disposed of 24,550 Common Stock (Right to Buy) (Disposition to Issuer) ($155K) · Disposed of 30,000 Common Stock (Disposition to Issuer) ($186K) |
| 27 Mar 2008 |
Form 4: Perkins Richard W, Director
Disposed of 17,500 Stock Option (Right to Buy) (Disposition to Issuer) ($96.3K) |
| 27 Mar 2008 |
Form 4: Noel David M, CFO & VP of Finance
Disposed of 83,500 Stock Option (Right to Buy) (Disposition to Issuer) ($722K) |
| 27 Mar 2008 |
Form 4: Hiebert Larry D, VP Operations
Disposed of 73,050 Stock Option (Right to Buy) (Disposition to Issuer) ($725K) · Disposed of 17,500 Stock Option (RIght to Buy) (Disposition to Issuer) ($74.6K) |
| 27 Mar 2008 |
Form 4: Hall James G, VP Technical Operations
Disposed of 50,125 Stock Option (Right to Buy) (Disposition to Issuer) ($138K) · Disposed of 2,000 Common Stock (Right to Buy) (Disposition to Issuer) ($12.6K) |
Loading...